Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank79
3Y CAGR-49.0%
5Y CAGR-28.1%
Studio
Year-over-Year Change

Diluted earnings per share

3Y CAGR
-49.0%/yr
Annual compound
5Y CAGR
-28.1%/yr
Recent deceleration
Percentile
P79
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM0.13+2212.7%
20240.01+100.1%
2023-6.45-771.9%
20220.96-70.1%
20213.21+386.4%
20200.66+772.1%
2019-0.10+94.7%
2018-1.85-137.2%
2017-0.78-39.3%
2016-0.56-